Puma Biotechnology, Inc. (PBYI)
7.25
-0.20
(-2.68%)
USD |
NASDAQ |
May 07, 16:00
7.26
+0.01
(+0.14%)
After-Hours: 20:00
Puma Biotechnology SG&A Expense (TTM) : 70.85M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 88.18M |
| Agios Pharmaceuticals, Inc. | 187.06M |
| Editas Medicine, Inc. | 36.53M |
| Trevi Therapeutics, Inc. | 12.19M |
| Phathom Pharmaceuticals, Inc. | 239.25M |